On June 14, the Nankai Business School MBA team, led by Ma Liang and advised by Xu Xinyuan, won first place in Group A at the 24th China MBA Entrepreneurship Competition National Semifinal with its “Digital-Intelligent Healthcare Platform” project, advancing to the national final. The project uses multimodal data analysis and deep learning to build a full-cycle “prevention, screening, diagnosis, treatment, and rehabilitation” system for high-risk prostate cancer patients, covering deep screening for high-risk identification, precision biopsy, minimally invasive focal therapy, postoperative follow-up, and integrated Chinese-Western medicine. It was recognized by the official report as a representative project in the healthcare and life sciences track. The national final will bring together 16 top teams selected from 495 projects.